Highlow study

 

METC 2012_347   ABR 40326  

 NL 40326.018.12  

NTR (Nederlands Trial Register) 3894  

NCT (Clinicaltrials.gov) 01828697


Low-molecular-weight heparin to prevent recurrent VTE in pregnancy: a randomized controlled trial of two doses


Number of inclusions

We are happy to announce that 679 patients have been enrolled since April 2013!


Netherlands: 345 patients (start: 1 April 2013)

France: 233 patients (start: 5 May 2015)

Ireland: 53 patients (start: 19 November 2015)

Belgium: 19 patients (start: 1 December 2015)

Norway: 21 patients (start: 15 February 2016)

USA: 2 patients (start: 25 July 2017)

Canada: 6 patients (start: 30 January 2018)

 

Are you a (international) physician willing to participate in this study? Please contact us at info@highlowstudy.org.